Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy children
10.1007/s004310050473
Saved in:
Main Authors: | Tan, A.Y.S., Connett, C.J., Connett, G.J., Quek, S.C., Yap, H.K., Lee, B.W., Meurice, F. |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Article |
Published: |
2013
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/47983 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX™ in healthy children
by: Lau, Y.-L., et al.
Published: (2013) -
Risk factors for breakthrough varicella in healthy children
by: Lim, Y.J., et al.
Published: (2013) -
Review of varicella zoster seroepidemiology in India and Southeast Asia
by: Lee, B.W.
Published: (2013) -
Review of varicella zoster seroepidemiology in India and Southeast Asia
by: Lee, B.W.
Published: (2016) -
CT appearance of Varicella Zoster lesions in liver and spleen in an immunocompetent patient
by: Venkatesh, S.K., et al.
Published: (2011)